Latest Options News

Page 11 of 782
PhosCo’s updated scoping study gives its 100%-owned Gasaat phosphate project in Tunisia a US$732 million post-tax NPV, 52% IRR and 49-year mine life. The economics are substantial, but the project still needs a mining concession, water supply, offtake agreements and about US$220 million in funding.
Maxwell Dee
Maxwell Dee
9 Nov 2026
Codan will acquire US mission-critical recording specialist Eventide Communications for about A$244 million, adding evidence capture and AI analytics to Zetron’s command-and-control software. The deal is expected to be mid-single-digit EPS accretive in its first full year, including synergies, but will also add debt and integration costs.
Sophie Babbage
Sophie Babbage
9 Nov 2026
OpenLearning has nearly tripled its placement to $430,000, taking commitments to its broader capital raising to $980,000 before the entitlement offer opens. The company could raise up to approximately $2.49 million, but the larger component remains dependent on shareholder participation.
Victor Sage
Victor Sage
9 Nov 2026
FireFly Metals has extended high-grade copper-gold mineralisation laterally and closer to surface at its Green Bay project in Canada, with results feeding into a revised resource estimate and feasibility study. The strongest intersections include 16.4 metres at 9.2% CuEq and 15.5 metres at 12.4% CuEq.
Maxwell Dee
Maxwell Dee
9 Nov 2026
Biotron CEO and executive director Glenn Gilbert has started more than two months ahead of schedule, immediately taking charge of a strategic review centred on SedRx. The review will also test development priorities, capital allocation and partnering options across the company’s drug portfolio.
Ada Torres
Ada Torres
9 Nov 2026
Sarytogan Graphite has launched a non-renounceable entitlement offer targeting up to $3.85 million, but only $1 million is underwritten and the issue depends on a Kazakh regulatory permit. The prospectus also flags going-concern uncertainty, substantial future project funding needs and dilution for shareholders who do not participate.
Maxwell Dee
Maxwell Dee
9 Nov 2026
Delorean has reached Financial Close on its $62.1 million NSW1 Horsley Park bioenergy facility, activating $30.5 million of government grants and a 25-year Brickworks gas supply agreement. Procurement can now begin, with construction targeted for early 2027, although Tanarra’s debt documentation and the project’s funding mix still warrant attention.
Victor Sage
Victor Sage
9 Nov 2026
49 Metals has secured a historical database pointing to broad, near-surface gold mineralisation and extensive gallium anomalism at its Buffalo Canyon project in Nevada. The data came at no cash cost, but the opportunity remains unverified and still requires new exploration.
Maxwell Dee
Maxwell Dee
9 Nov 2026
Viva Energy has put a medium-term growth plan around its convenience network while seeking a new government framework to keep the Geelong refinery operating beyond 2030. The strategy includes $350 million to $450 million of annual capital spending from 2027 to 2029 and a target net debt-to-EBITDA ratio of about 2.0 times.
Victor Sage
Victor Sage
9 Nov 2026
Zeotech has more than doubled the JORC-compliant Mineral Resource at its Toondoon Kaolin Project to 45.6 million tonnes, with Measured and Indicated material now accounting for about 80% of the estimate. The headline expansion strengthens the case for further AusPozz evaluation, but remains a resource upgrade rather than a mine plan or production forecast.
Maxwell Dee
Maxwell Dee
9 Nov 2026
Goodman Group and Digital Realty have acquired a 9.9% interest in NEXTDC through a jointly owned vehicle, putting two major data centre investors on the company’s register. The pair ruled out any present takeover or control proposal, but reserved the right to change position.
Victor Sage
Victor Sage
9 Nov 2026
Memphasys has secured its first New Zealand commercial agreement for Felix, committing a government-operated Auckland IVF clinic to a minimum of 1,200 cartridges over two years. The deal expands the device’s installed-clinic footprint, although undisclosed pricing leaves its financial contribution unclear.
Ada Torres
Ada Torres
9 Nov 2026

Browse the archive

Full archive